ACNP - Italian Periodicals Catalogue

AAAAAA

ITA
ENG

Results: 1-25 | 26-50 | 51-53

Results: 26-50/53

Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750

Authors: Barchiesi, F Calabrese, D Sanglard, D Di Francesco, LF Caselli, F Giannini, D Giacometti, A Gavaudan, S Scalise, G

Citation: F. Barchiesi et al., Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750, ANTIM AG CH, 44(6), 2000, pp. 1578-1584

In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically

Authors: Giacometti, A Cirioni, O Barchiesi, F Del Prete, MS Fortuna, M Caselli, F Scalise, G

Citation: A. Giacometti et al., In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically, ANTIM AG CH, 44(6), 2000, pp. 1694-1696

In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia

Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Fortuna, M Drenaggi, D Scalise, G

Citation: A. Giacometti et al., In vitro activities of membrane-active peptides alone and in combination with clinically used antimicrobial agents against Stenotrophomonas maltophilia, ANTIM AG CH, 44(6), 2000, pp. 1716-1719

Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection

Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Mocchegiani, F Riva, A Scalise, G Saba, V

Citation: A. Giacometti et al., Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection, ANTIM AG CH, 44(12), 2000, pp. 3306-3309

Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture

Authors: Giacometti, A Cirioni, O Del Prete, MS Barchiesi, F Scalise, G

Citation: A. Giacometti et al., Short-term exposure to membrane-active antibiotics inhibits Cryptosporidium parvum infection in cell culture, ANTIM AG CH, 44(12), 2000, pp. 3473-3475

Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection

Authors: Giacometti, A Cirioni, O Ghiselli, R Goffi, L Viticchi, C Mocchegiani, F Riva, A Orlando, F Saba, V Scalise, G

Citation: A. Giacometti et al., Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection, ANTIM AG CH, 44(10), 2000, pp. 2842-2844

In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens

Authors: Barchiesi, F Arzeni, D Fothergill, AW Di Francesco, LF Caselli, F Rinaldi, MG Scalise, G

Citation: F. Barchiesi et al., In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens, ANTIM AG CH, 44(1), 2000, pp. 226-229

Standardization of antifungal susceptibility testing and clinical relevance (vol 36, pg 68, 1998)

Authors: Espinel-Ingroff, A Barchiesi, F Hazen, KC Martinez-Suarez, JV Scalise, G

Citation: A. Espinel-ingroff et al., Standardization of antifungal susceptibility testing and clinical relevance (vol 36, pg 68, 1998), MED MYCOL, 37(2), 1999, pp. 147-147

Irritable bowel syndrome in patients with Blastocystis hominis infection

Authors: Giacometti, A Cirioni, O Fiorentini, A Fortuna, M Scalise, G

Citation: A. Giacometti et al., Irritable bowel syndrome in patients with Blastocystis hominis infection, EUR J CL M, 18(6), 1999, pp. 436-439

In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species

Authors: Barchiesi, F Schimizzi, AM Fothergill, AW Scalise, G Rinaldi, MG

Citation: F. Barchiesi et al., In vitro activity of the new echinocandin antifungal, MK-0991, against common and uncommon clinical isolates of Candida species, EUR J CL M, 18(4), 1999, pp. 302-304

Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates

Authors: Barchiesi, F Di Francesco, LF Arzeni, D Caselli, F Gallo, D Scalise, G

Citation: F. Barchiesi et al., Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates, EUR J CL M, 18(3), 1999, pp. 184-187

Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis

Authors: Giacometti, A Burzacchini, F Cirioni, O Barchiesi, F Dini, M Scalise, G

Citation: A. Giacometti et al., Efficacy of treatment with paromomycin, azithromycin, and nitazoxanide in a patient with disseminated cryptosporidiosis, EUR J CL M, 18(12), 1999, pp. 885-889

In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics

Authors: Giacometti, A Cirioni, O Barchiesi, F Fortuna, M Scalise, G

Citation: A. Giacometti et al., In vitro anticryptosporidial activity of ranalexin alone and in combination with other peptides and with hydrophobic antibiotics, EUR J CL M, 18(11), 1999, pp. 827-829

Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts

Authors: Cirioni, O Giacometti, A Drenaggi, D Ancarani, F Scalise, G

Citation: O. Cirioni et al., Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts, EUR J EPID, 15(4), 1999, pp. 389-393

In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa

Authors: Giacometti, A Cirioni, O Barchiesi, F Fortuna, M Scalise, G

Citation: A. Giacometti et al., In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa, J ANTIMICRO, 44(5), 1999, pp. 641-645

In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii

Authors: Cirioni, O Giacometti, A Barchiesi, F Fortuna, M Scalise, G

Citation: O. Cirioni et al., In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii, J ANTIMICRO, 44(5), 1999, pp. 653-659

In-vitro activity of polycationic peptides against Cryptosporidium parvum,Pneumocystis carinii and yeast clinical isolates

Authors: Giacometti, A Cirioni, O Barchiesi, F Caselli, F Scalise, G

Citation: A. Giacometti et al., In-vitro activity of polycationic peptides against Cryptosporidium parvum,Pneumocystis carinii and yeast clinical isolates, J ANTIMICRO, 44(3), 1999, pp. 403-406

In-vitro activity of dicationic aromatic compounds and fluconazole againstCryptococcus neoformans and Candida spp.

Authors: Del Poeta, M Bixel, AS Barchiesi, F Tidwell, RR Boykin, D Scalise, G Perfect, JR

Citation: M. Del Poeta et al., In-vitro activity of dicationic aromatic compounds and fluconazole againstCryptococcus neoformans and Candida spp., J ANTIMICRO, 44(2), 1999, pp. 223-228

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

Authors: Barchiesi, F Gallo, D Caselli, F Di Francesco, LF Arzeni, D Giacometti, A Scalise, G

Citation: F. Barchiesi et al., In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans, J ANTIMICRO, 44(1), 1999, pp. 65-70

In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

Authors: Barchiesi, F Tortorano, AM Di Francesco, LF Cogliati, M Scalise, G Viviani, MA

Citation: F. Barchiesi et al., In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp., J ANTIMICRO, 43(2), 1999, pp. 295-299

Antimicrobial activity of polycationic peptides

Authors: Giacometti, A Cirioni, O Barchiesi, F Del Prete, MS Scalise, G

Citation: A. Giacometti et al., Antimicrobial activity of polycationic peptides, PEPTIDES, 20(11), 1999, pp. 1265-1273

Contribution of zinc to reduce CD4(+) risk factor for 'severe' infection relapse in aging: parallelism with HIV

Authors: Mocchegiani, E Muzzioli, M Gaetti, R Veccia, S Viticchi, C Scalise, G

Citation: E. Mocchegiani et al., Contribution of zinc to reduce CD4(+) risk factor for 'severe' infection relapse in aging: parallelism with HIV, INT J IMMUN, 21(4), 1999, pp. 271-281

Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot

Authors: Scalise, A Barchiesi, F Viviani, MA Arzeni, D Bertani, A Scalise, G

Citation: A. Scalise et al., Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot, J INFECTION, 38(3), 1999, pp. 191-192

In vitro activities of polycationic peptides alone and in combination withclinically used antimicrobial agents against Rhodococcus equi

Authors: Giacometti, A Cirioni, O Ancarani, F Del Prete, MS Fortuna, M Scalise, G

Citation: A. Giacometti et al., In vitro activities of polycationic peptides alone and in combination withclinically used antimicrobial agents against Rhodococcus equi, ANTIM AG CH, 43(8), 1999, pp. 2093-2096

Comparison of four methods for DNA typing of clinical isolates of Candida glabrata

Authors: Di Francesco, LF Barchiesi, F Caselli, F Cirioni, O Scalise, G

Citation: Lf. Di Francesco et al., Comparison of four methods for DNA typing of clinical isolates of Candida glabrata, J MED MICRO, 48(10), 1999, pp. 955-963

Risultati: 1-25 | 26-50 | 51-53